The tender offer completion and Saba's massive stake reduction effectively ends the immediate activist campaign. The remaining 2.81% stake is small, and the standstill agreement limits Saba's ability to re-escalate. Monitor for any further open-market sales or a complete exit. The next catalyst is the 2028 annual meeting or any board-level changes.
Price Chart
Executive Summary
Saba Capital Management filed an amendment to its Schedule 13D for Virtus Dividend, Interest & Premium Strategy Fund (NFJ), reporting a reduction in its beneficial ownership to 1,961,367 common shares (2.81% of outstanding) after tendering 8,242,167 shares into the fund's self-tender offer at $15.92 per share on October 12, 2026. The filing also discloses a small open-market sale of 13,169 shares at $14.94 on October 14, 2026. This marks a significant de-escalation: Saba has largely exited its activist position following the completion of the tender offer, and the standstill agreement from April 2026 remains in effect through the earliest of the 2028 annual meeting, discontinuation of the tender offer, or October 21, 2026.
Key Financial Metrics
Key Facts
- Saba Capital's beneficial ownership dropped from a prior large position to 1,961,367 shares (2.81% of outstanding), calculated on 69,725,433 shares outstanding post-tender.
- On October 12, 2026, Saba tendered 8,242,167 shares into the fund's tender offer at $15.92 per share, receiving cash.
- On October 14, 2026, Saba sold an additional 13,169 shares in the open market at $14.94 per share.
- The total cost to acquire the remaining 1,961,367 shares cost approximately $23,383,246.
- The April 2026 standstill agreement restricts Saba from soliciting proxies, nominating trustees, or making shareholder proposals through the earliest of the 2028 annual meeting, discontinuation of the tender offer, or October 21, 2026.
- Saba states it may still engage with management on discount-to-NAV, governance, and strategic alternatives, but the tender offer exit signals reduced near-term activist pressure.
Financial Impact
Saba reduced its stake by approximately 8.2 million shares, receiving ~$131.2 million in cash from the tender offer at $15.92/share. Remaining stake valued at ~$29.3 million based on the $14.94 sale price.
Risk Factors
- Saba could re-engage if the standstill expires or if the discount-to-NAV widens materially.
- The fund's post-tender share count and NAV dynamics could shift, affecting future activist interest.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001062993-26-005348 |
| Document: 0001062993-26-005348-index-headers.html | 0001062993-26-005348 |
| Document: 0001062993-26-005348-index.html | 0001062993-26-005348 |
| Document: 0001062993-26-005348.txt | 0001062993-26-005348 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | SC 13D/A | $14.62 $14.66 | ▲ +0.27% | ▲ +1.29% | $14.59 (−0.21%) |
Oct 14, 2026 13d ago | SC 13D/A | $14.67 $14.81 | ▼ −0.95% | ▼ −0.50% | $14.59 (+0.55%) |
Oct 8, 2026 19d ago | SC TO-I/A | $14.36 $14.62 | ▲ +1.81% | ▲ +2.09% | $14.59 (+1.60%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers